ATE326243T1

Medium and matrix for long-term proliferation of cells

Abstract

The present invention provides a method of stimulating vascularization at a site in a mammal, said method comprising contacting said site with a matrix comprising gelatin and a nitric oxide inhibitor. The gelatin is preferably denatured collagen. The nitric oxide inhibitor may be a sulfonated moiety. The inhibitor may be an L-arginine analog, such as aminoguanidine, N-monoethyl L-arginine, N-nitro-L-arginine and D-arginine. The matrix may further comprise a nitric oxide scavenger, such as dextran, heparin, cysteine and cystine.

Term

Term ended

Projected expiry passed 9 July 2019, 7.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

84 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
11343798United States of AmericaA
33795999United States of AmericaA

Members84

Family members, oldest first
DocumentOfficeKind
CA2109065A1CanadaA1
WO9316685A1World Intellectual Property Organization (WIPO)A1
AU3729693AAustraliaA
NO933844D0NorwayD0
NO933844LNorwayL
EP0587840A1European Patent Office (EPO)A1
JPH06509812AJapanA
EP0587840A4European Patent Office (EPO)A4
AU663938B2AustraliaB2
US5614205AUnited States of AmericaA
CA2239498A1CanadaA1
WO9720569A2World Intellectual Property Organization (WIPO)A2
ZA9610297BSouth AfricaB
AU1119297AAustraliaA
WO9720569A3World Intellectual Property Organization (WIPO)A3
WO9832841A1World Intellectual Property Organization (WIPO)A1
AU6029298AAustraliaA
EP0865288A2European Patent Office (EPO)A2
US5824331AUnited States of AmericaA
US5830492AUnited States of AmericaA
US5834005AUnited States of AmericaA
US5908633AUnited States of AmericaA
EP0587840B1European Patent Office (EPO)B1
AU714465B2AustraliaB2
CA2332701A1CanadaA1
CA2337047A1CanadaA1
CA2337051A1CanadaA1
DE69327281D1GermanyD1
WO0002596A1World Intellectual Property Organization (WIPO)A1
WO0002600A1World Intellectual Property Organization (WIPO)A1
WO0002999A2World Intellectual Property Organization (WIPO)A2
AU4977299AAustraliaA
AU4977399AAustraliaA
AU5095299AAustraliaA
WO0002999A3World Intellectual Property Organization (WIPO)A3
JP2000507202AJapanA
DE69327281T2GermanyT2
NO309124B1NorwayB1
EP1094849A1European Patent Office (EPO)A1
EP1096962A1European Patent Office (EPO)A1
US6231881B1United States of AmericaB1
EP1098959A2European Patent Office (EPO)A2
US2001007658A1United States of AmericaA1
US6261587B1United States of AmericaB1
US2001010826A1United States of AmericaA1
US2001019841A1United States of AmericaA1
US6315994B2United States of AmericaB2
US6352707B1United States of AmericaB1
JP3291297B2JapanB2
JP2002520013AJapanA
AU756049B2AustraliaB2
AU757968B2AustraliaB2
AU758833B2AustraliaB2
EP1321516A2European Patent Office (EPO)A2
EP1321516A3European Patent Office (EPO)A3
FI111335BFinlandB
EP0865288B1European Patent Office (EPO)B1
CA2239498CCanadaC
AT247478TAustriaT
ATE247478T1AustriaT1
DE69629583D1GermanyD1
CA2109065CCanadaC
US6713079B2United States of AmericaB2
US6730315B2United States of AmericaB2
DE69629583T2GermanyT2
JP3606585B2JapanB2
EP1321516B1European Patent Office (EPO)B1
AT321126TAustriaT
ATE321126T1AustriaT1
DE69635940D1GermanyD1
EP1094849B1European Patent Office (EPO)B1
AT326243TAustriaT
ATE326243T1This recordAustriaT1
DE69931371D1GermanyD1
DE69635940T2GermanyT2
CA2337047CCanadaC
CA2337051CCanadaC
DE69931371T2GermanyT2
EP1096962B1European Patent Office (EPO)B1
AT449619TAustriaT
ATE449619T1AustriaT1
DE69941707D1GermanyD1
CA2332701CCanadaC
ES2337320T3SpainT3